SCPS OTC
Scopus BioPharma Inc.
1W: +0.0%
1M: +0.0%
3M: -20.0%
YTD: +0.0%
1Y: +33.3%
3Y: -99.1%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±30.8%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$8M
+28.9% ▲
Capital Expenditures
$2K
+22.4% ▲
Free Cash Flow
-$8M
+28.9% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$8M
-227.9% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$686K | -$3M | -$1M | -$27M | -$12M |
| Depreciation & Amort. | $0 | $664 | $1K | $2K | $2K |
| Stock-Based Comp. | $70K | $214K | $290K | $670K | $352K |
| Change in Working Capital | -$131K | $355K | $1M | $3M | $3M |
| Other Non-Cash Items | $0 | $0 | -$3M | $13M | $0 |
| Operating Cash Flow | -$747K | -$2M | -$3M | -$11M | -$8M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$4K | $0 | -$2K | -$2K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$4K | $0 | -$2K | -$2K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $2M | -$105K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $59K | $407K | -$1M | -$2M | $242K |
| Financing Cash Flow | $598K | $2M | $4M | $18M | $242K |
| Net Change in Cash | -$157K | $35K | $2M | $6M | -$8M |
| Cash End of Period | $2K | $37K | $2M | $8M | $125K |
| Free Cash Flow | -$747K | -$2M | -$3M | -$11M | -$8M |